You are here: Industry Insights > COVID-19

News List

Dr Harsh Vardhan inaugurates CEPI centralised network lab at DBT-THSTI Faridabad virtually expresspharma
January 06, 2021
The CEPI laboratory will be a great addition to the ability of THSTI to enhance the quality of services towards making vaccine and acceptability at global level, said Dr Harsh Vardhan.
Lui Franciosi Reviewing the Use of Glycosaminoglycans (GAG) Molecules as Potential New Treatments for COVID-19 prnewswire
January 05, 2021
Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be reviewing the pharmacological feasibility of using specific glycosaminoglycans (GAGs) for the treatment of SARS-CoV-2, i.e., COVID-19.
Health Canada Authorizes CytoSorb for Use in Hospitalized COVID-19 Patients prnewswire
January 05, 2021
CytoSorbents Corporation, a critical care immunotherapy leader commercializing its CytoSorb? blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients around the world, announces that Health Canada has ...
NextGen announce Ground-breaking Clinical Trial: Rapid breath test for Covid-19 detection to evaluate the efficacy of the vaccines including the Pfizer-BioNTech's vaccine prnewswire
January 05, 2021
NextGen Biomed Ltd., which is in the process of merging with Scent Medical Technologies Ltd., reports that Scentech-Medical received approval from the Shamir Medical Center (Asaf Harofe) Review Board (Helsinki committee) for a new clinical trial.
Ampio Provides Update on Clinical Trials for Ampion? Treatment of COVID-19 Patients prnewswire
January 05, 2021
Ampio Pharmaceuticals, Inc. announced an update on the launch of a new global clinical trial for intravenous ("IV") treatment of COVID-19 with Ampion and provided updates on its ongoing U.S. trial for inhalation treatment of COVID-19.
Codagenix, Serum Institute of India Announce Trial Single Dose Vaccine for COVID-19 americanpharmaceuticalreview
January 05, 2021
Codagenix and the Serum Institute of India (SIIPL) announced a Phase 1 clinical trial of COVI-VAC received regulatory approval by the Medicines and Healthcare Products Regulatory Agency (MHRA) and has commenced in London, UK.
aTyr Pharma reports positive data from Phase II Covid-19 drug trial pharmaceutical-technology
January 05, 2021
Biotherapeutics company aTyr Pharma has announced positive topline results from its Phase II clinical trial of ATYR1923 in hospitalised Covid-19 patients.
INOVIO, Advaccine Enter Exclusive COVID-19 DNA Vax Pact contractpharma
January 05, 2021
Partnership adds Asian manufacturing resource to INOVIO's global manufacturing consortium for INO-4800.
New virtual screening strategy identifies existing drug that inhibits COVID-19 virus worldpharmanews
January 04, 2021
A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19.
RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib prnasia
January 04, 2021
?RedHill Biopharma Ltd. announced that preliminary top-line data from its U.S. Phase 2 study with orally-administered opaganib (Yeliva?, ABC294640)[1] in patients hospitalized with COVID-19 pneumonia demonstrated positive safety and efficacy signals.